ZimVie (NASDAQ:ZIMV) Releases FY 2025 Earnings Guidance

ZimVie (NASDAQ:ZIMV) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.800-0.950 for the period, compared to the consensus estimate of 0.750. The company issued revenue guidance of $445.0 million-$460.0 million, compared to the consensus revenue estimate of $458.0 million.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC reissued a “buy” rating and set a $23.00 price objective on shares of ZimVie in a research note on Thursday.

ZimVie Stock Up 1.6 %

NASDAQ:ZIMV traded up $0.20 during trading hours on Friday, hitting $13.08. The stock had a trading volume of 28,277 shares, compared to its average volume of 247,359. The company has a market cap of $361.11 million, a PE ratio of -1.00 and a beta of 2.10. The business has a 50 day simple moving average of $13.75 and a two-hundred day simple moving average of $14.78. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie has a 1-year low of $12.12 and a 1-year high of $22.40.

ZimVie (NASDAQ:ZIMV) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.25 by $0.02. The business had revenue of $111.52 million for the quarter, compared to analysts’ expectations of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. Analysts predict that ZimVie will post 0.6 EPS for the current year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.